Molecular Detection


Company developing MRSA test raises $1.9 million

An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic panels to detect sepsis and gastrointestinal infections in hospitalized patients. Molecular Detection’s Detect Ready MRSA screening panel is currently marketed in Europe, […]


3 Philadelphia-area medical firms combine for more than $1M in funding

Three medical companies — a diagnostics business, an imaging company and another creating a treatment for head lice — were among nine businesses to receive a share of $1.8 million from Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP). Topaz Pharmaceuticals, based in Horsham, received $500,000. The company is developing  a topical cream that treats head […]


Molecular Detection raises $1.4M for disease diagnostics

Molecular Detection Inc. has raised $1.4 million in equity to develop a series of tests for infectious diseases, according to a regulatory filing. with the Securities and Exchange Commission. The company says its Detect-Ready technology offers a more quick and accurate means of diagnosing diseases. Its first product tests nasal samples for MRSA, a staph […]